Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • IVF In Chandrapur: Why Couples From Across Vidarbha Choose Aansh IVF With Dr Shweta Agarwal Health
  • Jayanti Dalmiya inaugurates 19th chapter of Flo in Vadodara Business
  • Kusum Tete – the popular tribal leader of Sundargarh Press Release
  • An E-commerce Revolution is Underway at Zimson Watches Lifestyle
  • ZERO DEBT COUNTRY CLUB Accelerates Global Expansion with TÜRKIYE & THAILAND Partnerships and Paddleball Launch Business
  • Aruna Goud’s Journey from India to Cannes Film Festival Lifestyle
  • FB Celebrations, creating a new era of event galas Lifestyle
  • Awards Trust of India to Host Atal Bharat Gaurav Sammaan, Bhartiya Sahitya Sammaan and Ambedkar Bharat Gaurav Sammaan in Guwahati on October 29, 2025 Lifestyle

Vivanza Biosciences Ltd reports Net Profit Jump of 37 per cent in 9MFY24; Total Income more than doubles to Rs. 23.50 crore

Posted on February 24, 2024 By

Ahmedabad (Gujarat) [India], February 24: Gujarat based Vivanza Biosciences Ltd (BSE – 530057) – engaged in the business of pharmaceuticals and agro trading has reported excellent financial results for the nine months ended December 2023. Company reported consolidated total income of Rs. 23.49 crore for the 9MFY24 with a 137% Y-o-Y growth as compared to total income of Rs. 9.92 crore in nine months of FY23. Net profit of the company also jumped 37% to Rs. 96.13 lakh during 9MFY24 as compared to net profit of Rs. 70.19 crore.

Company has reported strong growth over years with 3 Year CAGR of 23% sales and 69% in Net profits. Going forward, the company aims to fortify its position by strategically expanding its operations, bolstering manufacturing capabilities, and optimizing organizational capacities. The Company is looking at different opportunities in untapped markets and also across a value chain. Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units and plans for alliances with business associates in the global market

Vivanza Biosciences Limited is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. Over the last two decades, it has carved for itself, opportunities & faced challenges head on to achieve many milestones. Company offers diversified product portfolio in therapeutic areas including Diabetes, Anti Malaria, Nephrology and Cardiovascular. Company has 100 plus contract manufacturing clients and 32 plus products in pipeline. For FY23, company reported net profit of Rs. 71.6 lakh and Total income of Rs. 18.3 crore.

Earlier in March 2023, company approved stock split in the ration of 1:10. Company approved subdivision of one Equity Share having face value of Rs.10 each into 10 Equity Shares of Rs. 1 each.

The company has further taken major initiatives like strong marketing efforts, focus on cost reduction through inventory management techniques, introduction of new products and manufacturing process without compromising quality of products and retain talented employees etc.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: Seamlessly Blending Tradition with Innovation: Bharat Tex 2024 Unveils February 26th at New Delhi!
Next Post: Varmora Granito Unveils Flagship Showroom in Dewas, Madhya Pradesh

Related Posts

  • Nessa Illumination Technologies Pvt Ltd Launched Smart Light and Hybrid Solar High Mast at REI Expo 2024 Business
  • Businessman Kshitiz Adukia realises the dream of three young entrepreneurs to launch Gujarat’s first NFT Business
  • India’s Rap Maestro Rapper Badshah Redefines Luxury and Entertainment Norms Business
  • NAR-India and RICS India join hands to Launch Executive Leadership Programme for Real Estate Business Management Business
  • INNER WELLNESS- Paving A Way to Align Your Mental, Spiritual and Physical Health Business
  • Lagnam Spintex Reports Strong Q2 & H1 Fy27 Performance; Ebitda Rises 98% In Q2 And 64% In H1fy27 Business

Recent Posts

  • IBMA Organises First-Ever Indian Lead Battery Conference 2026 in Goa
  • Why Creator-Gear is a B2B Business now: agencies, schools, and production houses?
  • Prateek Group Brings The New Era of Luxury Real Estate
  • Top Bathroom Tile Brands in India: Wall, Floor and Anti-Skid Options Compared
  • Parul University moves to 401-500 band in Times Higher Education (THE) Interdisciplinary Science Rankings 2027

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • NG-NeXT Embracing Change With The Excitement Of Onboarding Accomplished CSO Business
  • Mr, Miss and Mrs Tamizhagam 2024 Crowned: Bharadwaj, Anusha, and Rakshana Lead the Winners Entertainment
  • Lakshya Powertech Limited Announces H2 FY26 and FY26 Results Business
  • Cost Savings and Efficiency Gains: The Financial Benefits of Cloud-Based Construction ERP Technology
  • Vasu Foundation Commits to Planting 1.08 Lakh Trees by 2035 After Completing Mission 10,008 National
  • Economic Times Presents “Future of Marketing & Branding Masterclass” a workshop with Marketing Legends Prof. Philip Kotler & Dr. David Aaker Business
  • Marg Mart: A Life-Saver in the Age of Covid-19 Business
  • Amber Nine by Alisha: Redefining Luxury Jewelry with Timeless Elegance Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme